<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0204870.ref026">
 <label>26</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Roemer</surname>
   <given-names>MG</given-names>
  </name>, 
  <name>
   <surname>Advani</surname>
   <given-names>RH</given-names>
  </name>, 
  <name>
   <surname>Ligon</surname>
   <given-names>AH</given-names>
  </name>, 
  <name>
   <surname>Natkunam</surname>
   <given-names>Y</given-names>
  </name>, 
  <name>
   <surname>Redd</surname>
   <given-names>RA</given-names>
  </name>, 
  <name>
   <surname>Homer</surname>
   <given-names>H</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome</article-title>. 
  <source>Journal of clinical oncology: official journal of the American Society of Clinical Oncology</source>. 
  <year>2016</year>;
  <volume>34</volume>(
  <issue>23</issue>):
  <fpage>2690</fpage>â€“
  <lpage>7</lpage>. 
  <pub-id pub-id-type="doi">10.1200/JCO.2016.66.4482</pub-id> ; PubMed Central PMCID: PMCPMC5019753.
  <?supplied-pmid 27069084?>
  <pub-id pub-id-type="pmid">27069084</pub-id>
 </mixed-citation>
</ref>
